Express News | Marinus Pharmaceuticals to Provide Business Update and Report First Quarter 2024 Financial Results on May 8, 2024

ReutersMay 1 08:00 ET

How Is The Market Feeling About Marinus Pharma?

Marinus Pharma's (NYSE:MRNS) short percent of float has fallen 3.64% since its last report. The company recently reported that it has 3.47 million shares sold short, which is 6.35% of all regular shar

BenzingaApr 29 10:45 ET

Market Cool On Marinus Pharmaceuticals, Inc.'s (NASDAQ:MRNS) Revenues Pushing Shares 84% Lower

The Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) share price has fared very poorly over the last month, falling by a substantial 84%. For any long-term shareholders, the last month ends a year to fo

Simply Wall StApr 25 07:33 ET

Express News | Tang Capital Partners LP Reports 8.2% Passive Stake in Marinus Pharmaceuticals Inc as of April 16 - SEC Filing

Moomoo 24/7Apr 19 06:12 ET

Marinus Pharmaceuticals Is Maintained at Buy by Truist Securities

Marinus Pharmaceuticals Is Maintained at Buy by Truist Securities

Dow JonesApr 18 07:24 ET

Express News | Marinus Pharmaceuticals Inc : Truist Securities Cuts Target Price to $10 From $25: Truist Securities Cuts Target Price to $10 From $25

Moomoo 24/7Apr 18 06:55 ET